Monday, December 18, 2023

Small Molecule API Market Overview by Size, Share, Trends & Growth

Market Insights:

Market Research Future (MRFR)’s latest study asserts that the global small molecule API market is set to expand at a CAGR of 7.0% during the forecast period 2023 to 2030. The global small molecule API market share is set to reach a healthy growth by 2030. The increased investments in the research & findings coupled with government support are likely to propel the market growth in the forthcoming years.

The pharmaceutical industry is presently making massive profits and is equipped with developed infrastructure. The pharmaceutical industry is anticipated to expand in the foreseeable future. This, in turn, is expected to drive the growth of the small molecule API market. Additionally, the increase in the prevalence of diseases coupled with the discovery of new viruses and diseases is prognosticated to affect the small molecule API market proliferation positively.

Some of the factors responsible for favoring the expansion of the small molecule API market report include growing demand for small molecule drugs, rising access to the medication in developing and underdeveloped countries, entry of big CMOs into the market, etc. Furthermore, rising burden of cardiovascular diseases and cancer is forecasted to intensify the competition among the players of the small molecule API market. According to the American Cancer Society, 1,735,350 new cancer cases and 609,640 cancer deaths are estimated in the U.S. alone.

Market Segmentation:

By type, the small molecule API market trends has been segmented into synthetic/chemical API, and biological API. Synthetic/chemical API segment currently holds 81.4% share of the market. It is likely to retain its pole position over the forecast period.

By application, the global small molecule API market overview is segmented into cardiovascular, oncology, diabetes, immunological disorders, and others. The cardiovascular segment held the maximum share of the market in 2015. It is anticipated to show positive growth across the review period.

By manufacturing method, the small molecule API market has been segmented into in-house and contract.

Competitive Dashboard:

Small Molecule API Market players profiled in the report are Albemarle Corporation, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline Plc, Lonza, Merck Sharp & Dohme Corp., Allergan Plc, Aurobindo Pharma, Cambrex Corporation, Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Novartis AG, Pfizer Inc., and Siegfried AG.

Regional Analysis:

By region, the global small molecule API market insights has been segmented into North America, Europe, Asia Pacific, and the Middle East & Africa. North America is the largest market for small molecule API. It is expected to retain a significant market share through the assessment period. The factors favoring the expansion of the regional market include developed healthcare sector, availability of funds, increasing clinical trials, rising burden of cancer, etc.

Europe is the second largest small molecule API market. It is estimated to exhibit healthy growth over the next few years. The growth is attributable to the initiatives undertaken by the governments to support the expansion oh pharmaceutical industry. Furthermore, the availability of funds coupled with the adoption of next-gen healthcare technology is anticipated to aid market proliferation in the region.

Asia Pacific is projected to thrive at the highest CAGR during the review period. The Asian countries have an abundance of raw materials required for drug manufacturing. Additionally, low labor cost and regulatory relaxations have aided profit maximization for the regional market players. Asia Pacific is one of the significant exporters of small molecule drug, and the trend is projected to continue over the next few years.

The Middle East & Africa is set to exhibit steady growth. The African regions lack proper healthcare facilities and resonate strong growth opportunities. However, the Middle Eastern countries such as Qatar and Kuwait are expected to witness considerable growth due to the developed healthcare sector and increasing awareness.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Cryotherapy and Cryosurgery Market Outlook Overview, Trends,Share and Forecast by 2032

Global Cryotherapy and Cryosurgery Market   - Overview

Cryotherapy and Cryosurgery Market Share was valued at USD 0.35 billion in 2022. The cryotherapy and cryosurgery market industry is projected to grow from USD 0.37415 Billion in 2023 to USD 0.63 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.9% during the forecast period (2023 - 2032). 

Cryotherapy, this medical practice has been used since ages. Cryotherapy and cryosurgery both these medical processes are carried on using low temperature. Cryotherapy treatment uses extreme cold temperature. Cryosurgery is a part of cryotherapy that used to destroy or remove disease tissues. It is used to cure some types of cancer and to remove skin tags warts, moles etc. Cryotherapy is very useful in treating skin problems, heart diseases, injuries, improving immunity, increasing blood pressure etc. Cryotherapy is also widely used for treating sport related injuries. Continuous innovation and technological advancement are leading the growth of cryotherapy and cryosurgery market. Increasing awareness and consciousness about skin and related diseases are also driving the growth of this market along with increasing number of cancer treatments. Cryotherapy and cryosurgery market is growing moderately.

Growing numbers of cancer patients and increasing heart diseases are driving the growth for the cryotherapy and cryosurgery treatments. Cryotherapy is widely used in sports industry worldwide to cure injuries and pain management. Medical devices manufacturers are investing money in R&D to develop innovative products for the market.

The cryotherapy and cryosurgery market is segmented by type, application, end user, and region. By type, the market is divided into ice pack therapy, instant ice pack therapy, whole body cryotherapy, partial body cryotherapy, and internal cryotherapy. By application, the market is categorized into dermatology, oncology, pain management, cardiology, ophthalmology, gynecology, urology, and others.

Increasing healthcare facilities and technological advancement are driving the growth for the market of cryotherapy and cryosurgery. However, some factors are prohibiting the growth for the market such as side effects of the treatment, impact cryotherapy cost is high of surgery, high price of medical devices etc.

Cryotherapy & Cryosurgery Market – Segmentations

The report - The Cryotherapy and Cryosurgery market outlook is segmented into four key dynamics, for the convenience of the report and enhanced understanding: -

By Types                     : Comprises Instant Ice Pack Therapy, Ice Pack Therapy, Whole Body Cryotherapy, Internal Cryotherapy and Partial Body Cryotherapy, among others.

By Device Types          : Cryo Chambers, Cryogun, Gas Cylinders, Cryosaunas, Cryo Probes, and Thermocouple Devices, among others.

By Applications          : Oncology, Dermatology, Pain Management, Cardiology and Trigeminal Neuralgia, among others.

By Regions                  : North America, Europe, APAC and Rest-of-the-World (RoW).

The Ice Pack Therapy segment by Types is estimated to account for 28% of the market share, while The Instant Ice Pack Therapy segment will garner 23% of the market share.

The Whole-Body Cryotherapy segment will evaluate for 16% of the market share.

The Partial Body Cryotherapy segment will pull around 21% market share, whereas the Internal Cryotherapy segment will account for 12% of the Market Share.

Market Players

The Cryotherapy and cryosurgery market research are Impact Cryotherapy (US), Galil Medical Inc. (US), HealthTronics, Inc.(US), KryoLife Inc (US), Medtronic (Republic of Ireland), GRAND Cryo LLC (Russia), Erbe USA, Incorporated, Wallach Surgical Devices (US), MedGyn Products, Inc. (US).

Cryotherapy & Cryosurgery Market – Geographical Analysis

Globally, North America region is expected to lead the Cryotherapy and Cryosurgery market accounting for a significant market share.  Factors substantiating the market growth of this region include growing demand for the minimally invasive procedures, supported by the growing number of patients suffering from the chronic diseases such as Cancer.

Whereas the world’s second-largest market for Cryotherapy and Cryosurgery - Europe is expected to demonstrate a healthy growth during the review period. Factors such as the well-proliferated healthcare sector, witnessing the growing number of advanced treatment facilities fuelled by the growing demand for better healthcare infrastructure and increasing healthcare expenditures are driving the growth in the Europe market.

The Asia-Pacific market is emerging as a lucrative market for Cryotherapy and Cryosurgery owing to the rising number of patients suffering from Cancer along with the other chronic diseases and the growing population that is increasingly adopting the sedentary lifestyle. Increasing funding support from the private and public bodies are paying off well, increasing R&D activities, and eventually are supporting the market growth in the region.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Microsurgery Market Overview with Future Growth, Trends & Forecast by 2030

Market Analysis

The global microsurgery market share is expected to touch USD 1.9 billion by 2030 at a prodigious 7.10% CAGR over the predicted years 2022-2030. Microsurgery is an immensely developing discipline of surgery which deals with surgeries associated to small structures namely nerves and blood vessels. Regardless of its comparatively recent advent, microsurgery has created a niche in different domains of surgery within a brief time period. Be it in the domain of reconstructive surgery, plastic surgery, ophthalmic surgery, orthopedic surgery, pediatric surgery, neurosurgery or vascular surgery, microsurgery is gaining immense recognition everywhere. The principles of this surgery rests on three key components- instruments, illumination and magnification. All these components should have a proper coordination for optimal results.

There are many factors that is fueling the growth of the microsurgery market report. The different market trends and factors in this market according to an analysis performed by Market Research Future (MRFR) include rising geriatric population, advancements in technology, rising existence of chronic diseases such as periodontal diseases, dental caries, cancer, arthritis, cataract and others, growing demand for improved treatment of diseases, increasing popularity of cosmetic and aesthetic surgeries and growing demand for surgeries that are minimally invasive. On the contrary factors such as lack of trained experts, complexities resulting from a person’s anatomical condition and soaring cost of surgeries are anticipated to hinder the growth of the microsurgery market.

Market Segmentation

In the Market Research Future (MRFR) report, the microsurgery market has been segmented on the basis of procedure, equipment, application and end-user.

Based on procedure, it is segmented into vascular anastomoses, free flap tissue transfer, replantation and transplantation. Of these, the transplantation segment has the maximum market share followed by the replantation segment that is experiencing the fastest growth.

Based on application, the microsurgery market trends is segmented into maxillofacial surgery, oral surgery, neurosurgery, gynecological surgery, plastic surgery, ophthalmology, general surgery and others. Of these, general surgery is expected to have the maximum share in the microsurgery market followed by neurosurgery that is expected to have the fastest growth during the predicted years.

Based on equipment, it is segmented into suture materials, microsurgical instruments, microscopes and others. Of these, the microsurgical instruments will lead the market followed by microscopes that is anticipated to have the fastest growth.

Based on end-user, the microsurgery market is segmented into research organizations, ambulatory surgical centers, hospitals and clinics. Of these, the ambulatory surgical segment is likely to have the fastest growth during the predicted years.

Key Players

Global microsurgery market players leading industry are include Halma Plc, AROSurgical Instruments, Microline Surgical, Tisurg Medical Instruments Co., Ltd., Peter Lazic GmbH, Microsurgery Instruments, Inc., Carl Zeiss Meditec AG, Medtronic Plc, Zimmer Biomet Holdings, Alcon (Novartis), Smith & Nephew, Stryker Corporation, Ethicon Inc., Synovis Micro Companies Alliance, Inc., a B. Braun Company, and S&T AG, Aesculap, Inc.

Regional Analysis

Based on region, the microsurgery market overview covers growth opportunities and latest trends across North America, Europe, Asia Pacific and the Middle East and Africa. Of these, North America will be the driving force in the microsurgery market over the predicted years. The factors that can be attributed to the growth of the market in this region include growing prevalence of cancer, arthritis, cataracts and periodontal diseases, presence of healthcare infrastructure that is well-developed and rapid technological advancement. In Asia Pacific region the microsurgery market is anticipated to grow at the fastest pace at a striking 6.91% CAGR over the predicted years. The different factors that are contributing towards the fastest growth of this market in this region include need for surgical treatment procedures that are minimally invasive, high healthcare expenditure and increasing geriatric population.

Related topics-

Ticagrelor Market

Stereotactic Surgery Devices Market

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Reading Glasses Market Outlook : A Forecast of the Market Share, and Trends

Market Overview

The global reading glasses market share is expected to reach USD 64.1 billion by 2032, at a CAGR of 5.70% during the forecast period (2023-2032). The market is being driven by the aging global population, increasing screen time, and the growing demand for affordable and fashionable reading glasses.

Key Players

MRFR recognizes the following companies as the key players in the global Reading Glasses market— Bausch & Lomb Incorporated., EssilorLuxottica, Carl Zeiss, Johnson & Johnson Services, Inc., Hoya Corporation, De Rigo Vision S.p.A., ZENNI OPTICAL, INC., and ThinkOptic Inc.

Region-wise Outlook

The region-wise outlook for the reading glasses market is as follows:

  • North America: North America is currently the largest market for reading glasses, accounting for over 40% of the global market share. This is due to the high disposable incomes of consumers and the high awareness of eye care in the region.
  • Europe: Europe is the second largest market for reading glasses, accounting for over 30% of the global market share. The market is driven by the aging population in the region and the increasing prevalence of presbyopia.
  • Asia-Pacific: Asia-Pacific is the fastest-growing market for reading glasses, with a CAGR of over 7%. The growth is driven by the increasing disposable incomes of consumers, the growing awareness of eye care, and the increasing prevalence of presbyopia in the region.
  • Latin America: The Latin American reading glasses market is expected to grow at a CAGR of over 6% during the forecast period. The growth is driven by the increasing disposable incomes of consumers and the growing awareness of eye care in the region.
  • Middle East & Africa: The Middle East & African reading glasses market is expected to grow at a CAGR of over 5% during the forecast period. The growth is driven by the increasing disposable incomes of consumers and the growing awareness of eye care in the region.

Overall, the global reading glasses market is expected to grow steadily in the coming years, with Asia-Pacific being the fastest-growing region.

Growth Drivers

The growth of the global reading glasses market outlook is being driven by a number of factors, including:

Aging global population: The aging global population is one of the key drivers of the reading glasses market. As people age, they are more likely to develop presbyopia, an age-related eye condition that makes it difficult to focus on close objects.

Increasing screen time: The increasing use of digital devices, such as smartphones, tablets, and computers, is also driving the demand for reading glasses. This is because staring at screens for extended periods of time can strain the eyes and make it difficult to focus on close objects.

Growing demand for affordable and fashionable reading glasses: There is a growing demand for affordable and fashionable reading glasses. This is because people want to be able to wear reading glasses that look good and fit their lifestyle.

Segment Analysis

The global reading glasses market has been segmented into age group, type and distribution channel.

On the basis of age group, the market is segmented into less than 18 years, 18-64 years, and 65 years and greater. The 18-64 years segment dominated the global market in 2022. Presbyopia, hyperopia, and farsightedness are three adult vision disorders that are becoming more common.

Based on type, the global reading glasses market has been segmented into prescription reading glasses and OTC reading glasses. Prescription reading glasses segment dominated the global Reading Glasses market in 2022. This can be attributable to the public's growing understanding of the value of choosing the right eyeglass strength.

Based on distribution channel, the global reading glasses market has been segmented into retail stores, online sales channels, and ophthalmology clinics. Retail stores segment dominated the global market in 2022. This may be related to the fact that customers prefer to visit actual stores to examine the goods in person and decide whether or not it is suitable for them.

Challenges

The global reading glasses market faces a number of challenges, including:

Competition from online retailers: Online retailers are offering a wide range of reading glasses at competitive prices. This is making it difficult for traditional brick-and-mortar retailers to compete.

Counterfeit products: There is a growing problem with counterfeit reading glasses being sold online and in some brick-and-mortar stores. This can pose a health risk to consumers.

Consumer awareness: Many consumers are not aware of the importance of getting a proper eye exam before buying reading glasses. This can lead to consumers buying the wrong type of reading glasses or buying glasses that are not strong enough.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

United States of America

Wolff Parkinson White Syndrome Market Outlook: SWOT Analysis, And Key Industry Developments

Market Highlights:

The Wolff Parkinson White Syndrome Market Share is projected to reach USD 1,659.9 Million by 2030 at 5.2% CAGR during the forecast period 2022-2030.

Wolff-Parkinson-White (WPW) syndrome is a rare congenital heart disorder involving irregularities in the electrical transmission system of the heart. In WPW syndrome, an abnormal alternate electrical pathway exists resulting in arrhythmias (abnormal heartbeat rhythms) and tachycardia (faster than normal heartbeats). WPW is congenital but, symptoms may not become apparent until adolescent. Approximately 10 to 20 percent of individuals with WPW syndrome have a congenital heart defect, such as Ebstein’s anomaly. The disorder’s estimated prevalence is 3 people per 1,000 people in the United States.

The market is driven by advancements in medical devices such as pacemakers and radiofrequency catheter ablation. Product development of these devices in terms of miniaturization of devices and better battery backup is driving the market.

The market drivers for Wolff Parkinson White syndrome are increasing screening for genetic diseases, rising awareness, growing income of people etc. The market restraints are the poor cure rates, poor efficacy and efficiency of effective drugs etc.

Global Wolff Parkinson White syndrome Market Players
Wolff Parkinson White syndrome market players profiled in the report are AngioDynamics, Medtronic, Boston Scientific Corporation, St. Jude Medical, LLC, Abbott, GlaxoSmithKline LLC, Teva Pharmaceutical Industries, Sanofi S.A., and Novartis International AG and others.

Regional Analysis
The Americas which are dominated by the US account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new instruments and surgical techniques in the US drives the Wolff Parkinson White syndrome market. The good reimbursement scenario and the greater awareness in the developed regions drive the market.

Europe is the second largest market in the world due to high income and healthcare penetration. The European region is dominated by Germany and France. The presence of large screening programs in the developed regions drives the market for Wolff Parkinson White syndrome.

Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Wolff Parkinson White syndrome Market” Research Report – Forecast till 2023.

Segmentation
The global Wolff Parkinson White syndrome market outlook has been segmented on the basis of types, diagnosis, treatment and end users.

Based on types, Wolff Parkinson White syndrome has been segmented as type A and type B.

Based on diagnosis, the market has been segmented as Electrocardiogram (ECG), Electrophysiological testing, and others.

Based on treatment, the market has been segmented as drugs, cardioversion, radiofrequency catheter ablation, surgery, artificial pacemaker and others.

Based on the end users, the market has been segmented as hospitals & clinics, academic & research and others.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Gene Panel Market Outlook: growth, drivers and forecast report by 2032

Market Overview

The Global Gene Panel Market Share is expected reach USD 3.49 billion by 2032 at 13.72% CAGR during the forecast 2023-2032.

A gene panel test is a type of genetic testing that sequences the entire genome of a patient accused of carrying diseases based on genetic abnormalities or that are genetically inherited, such as cancer, cardiovascular disease, and many others. Pharmacogenetics, congenital disease detection, and cancer risk assessment are just a few of the uses for gene panels.

A gene panel is a useful diagnostic tool for detecting and predicting rare genetic changes that spread diseases like Lynch Syndrome (hereditary non-polyposis colorectal cancer), which puts patients at a higher risk than other cancers like stomach, ovarian, and colon cancer. Targeted gene panels can be used to look for specific gene mutations linked to a disease or a phenotypic attribute that is being studied or researched. Recent breakthroughs in gene sequencing have resulted in the development of user-specific gene panels.

Market Segmentation

Design, Application, Technique, and Geography are the four Gene Panel Market Report Segment.

Techniques for obtaining market data include:

       Amplicon-Based Methodology

       Hybridization-Based Methodology

The market is divided into two types of techniques: The amplicon-Based Approach and the Hybridization-Based Approach. The hybridization-based approach had the biggest market share and was expected to increase at a CAGR of 22.22 percent over the projection period.

Global Gene Panel Market, By Design

       Predesigned Gene Panels

       Customized Gene Panels

The Global Gene Panel Market Outlook has been split into Predesigned Gene Panels and Customized Gene Panels based on design.

Global Gene Panel Market, By Application

       Pharmacogenetics

       Cancer Risk Assessment

       Diagnosis of Congenital Disorders

       Others

Based on Application, the market is segmented into Pharmacogenetics, Diagnosis of Congenital Disorders, Cancer Risk Assessment, Others.

Competitive Landscape

The most prominent major Gene Panel Market Players in the global market are mentioned below:

Agilent Technologies Inc. (U.S.), Thermo Fisher Scientific (U.S.), Hoffmann-La Roche Ltd (Switzerland), Qiagen (Germany), Illumina Inc. (U.S.), BGI Genomics (China), Integrated DNA Technologies, Inc. (U.S.), GENEWIZ (U.S.), Novogene Corporation (U.S.), Personalis, Inc. (U.S.), GATC Biotech AG (Germany), ArcherDX, Inc. (U.S.), GeneDX (Switzerland), CENTOGENE AG (Germany),

Regional Classification

The global Gene Panel Market Data is divided into five regions: the Middle East, North America, Asia Pacific, Latin America, Europe, and Africa.

Because of increased collaborations and partnerships among industry participants, North America is likely to have a leading position in the global gene panel market over the forecast period. In October 2019, for example, Illumina, Inc., an American biotechnology company, and QIAGEN, a German molecular diagnostics company, established 15-year cooperation to expand the availability of next-generation sequencing-based clinical diagnostics for gene panels.

Industry News

·        Increased cancer cases of various sorts, such as cancer of the ovaries, fallopian tubes, breast cancer, prostate cancer in males, and rising global prevalence of chronic diseases, are driving the gene panel market. Furthermore, a growing number of initiatives by various companies throughout the world and other advantages of gene panels are important factors encouraging the gene panel market. On the other hand, strict policies and regulations for pharmaceutical companies and protection issues about genetic data are the major challenges faced by the gene panel market and hampering the growth.

·        One of the key reasons the area has become a primary medical service provider is its booming biotechnology industry and greater knowledge of new technologies. Even though gene panel testing is reliable, the test's limitations and inaccuracy are predicted to stymie industry growth. Moreover, the market is expected to be stifled due to rigorous laws and safety concerns around gene panels. Regardless, continued genome sequencing research and innovation are projected to increase the demand for genetic testing.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

 

Nuclear Imaging Devices Market Outlook & Regional Analysis 2032

Market Highlights

The global Nuclear Imaging Devices Market Share is expected to grow significantly over the forecast period. It is anticipated that the market is projected to register a CAGR of 5.1% over the forecast period 2023-2032.

The increasing prevalence of cardiovascular disorders is one of the key factors driving the nuclear imaging devices market. As per the report published by the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease.

Various other factors such as the advancements in radiotracers, acceptance of nuclear imaging devices in ambulatory settings, increasing geriatric population, untapped emerging markets, rise in regulatory approvals, and increasing investment on diagnostic imaging centers are also expected to propel the growth of the market.

However, the high cost of the nuclear imaging device, shorter half-life of radiopharmaceuticals can hamper market growth over the forecast period.

Key Players

the global nuclear imaging devices market players are

Philips Healthcare,

Digirad Corporation,

Neusoft Medical Systems Co., Ltd.,

Progenics Pharmaceuticals Inc.,

Cannon Inc.,

Surgiceye GmbH,

CMR Naviscan,

Mediso Medical Imaging Systems Ltd.,

Agfa-Gevaert Group,

General Electric Company,

DDD-Diagnostic A/S,

Spectrum Dynamics Medical,

FMI Medical Systems, Inc.,

Segamicorp, and others.

Segmentation

The global nuclear imaging devices market is segmented based on technology, application, end user, and region.

·        The global nuclear imaging devices market outlook, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.

·        Based on application, the market is segmented into oncology, cardiology, neurology, and others.

·        Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.

·        The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.

Regional Analysis

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.

The nuclear imaging devices market insights in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European nuclear imaging devices market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The nuclear imaging devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The nuclear imaging devices market in the Middle East & Africa has been segmented into the Middle East and Africa.

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Growing Adoption of Non-Invasive Tattoo Removal Techniques: Market Implications

Tattoo Removal Market: Overview and Trends The tattoo removal market is a dynamic and growing sector within the global aesthetics industry...